Authors:
ILLEI G
MCCOY A
GOURLEY M
CRANE M
YARBORO C
VAUGHAN E
DAVIS J
PANDO J
AUSTIN H
BALOW J
KLIPPEL J
BOUMPAS D
Citation: G. Illei et al., RENAL FLARES IN PATIENTS WITH PROLIFERATIVE LUPUS NEPHRITIS (LN) TREATED WITH IMMUNOSUPPRESSIVE THERAPY - CLASSIFICATION, PREVALENCE AND OUTCOMES, Arthritis and rheumatism, 41(9), 1998, pp. 1257-1257
Authors:
CSAKO G
PUCINO F
YARBORO CH
NAGY B
WESLEY R
GOURLEY M
EGGERMAN TL
HOEG JM
SCOTT D
COSTELLO R
BALOW JE
KLIPPEL JH
Citation: G. Csako et al., APOLIPOPROTEIN(A) ISOFORMS AND ANTICARDIOLIPIN ANTIBODIES AS PREDICTORS OF PREMATURE THROMBOEMBOLIC EVENTS IN SLE PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 1643-1643
Authors:
WU J
BANSAL V
ARNETT F
REVEILLE J
GINZLER E
GOURLEY M
RAMSEYGOLDMAN R
SALMON J
EDBERG J
KIMBERLY R
Citation: J. Wu et al., THE FC-GAMMA-RIIIA 176F V POLYMORPHISM ASSOCIATES WITH THE SLE PHENOTYPE IN CAUCASIANS AND AFRICAN-AMERICANS (AA)/, Arthritis and rheumatism, 40(9), 1997, pp. 1709-1709
Authors:
LEFKOWITH JB
KIEHL M
RUBENSTEIN J
DIVALERIO R
BERNSTEIN K
KAHL L
RUBIN RL
GOURLEY M
Citation: Jb. Lefkowith et al., HETEROGENEITY AND CLINICAL-SIGNIFICANCE OF GLOMERULAR-BINDING ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, The Journal of clinical investigation, 98(6), 1996, pp. 1373-1380
Authors:
BULBUL R
DAVIS J
YARBORO C
GOURLEY M
KLIPPEL J
ARAYSSI T
BRANIGAN P
HUDSON A
ROTHFUSS S
SCHUMACHER HR
Citation: R. Bulbul et al., TREATMENT RESPONSES IN CHLAMYDIA-TRACHOMATIS ASSOCIATED ARTHRITIS - AN OBSERVATIONAL STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 942-942
Authors:
ROSIN M
YARBORO C
NUZZO V
KLIPPEL J
GOURLEY M
Citation: M. Rosin et al., CORTICOSTEROID (CS) EFFECTS ON BONE-MINERAL DENSITY (BMD) IN PATIENTSWITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 39(9), 1996, pp. 1587-1587
Citation: Jb. Lefkowith et al., GLOMERULAR BINDING-ANTIBODIES IN LUPUS NEPHRITIS PATIENTS - CHARACTERIZATION AND CLINICAL-SIGNIFICANCE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 925-925
Citation: M. Kiehl et al., GLOMERULAR BINDING-ANTIBODIES IN LUPUS NEPHRITIS PATIENTS - CHARACTERIZATION AND CLINICAL-SIGNIFICANCE, Arthritis and rheumatism, 38(9), 1995, pp. 966-966
Authors:
GOURLEY M
HERION D
GLUCK V
PANDO J
YARBORO C
KLIPPEL J
SALLIE R
Citation: M. Gourley et al., GENETIC AND METABOLIC MARKERS OF BONE-MINERAL DENSITY (BMD) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 38(9), 1995, pp. 1230-1230
Authors:
GOURLEY M
AUSLIN H
YARBORO C
VAUGHAN E
MUIR J
LINDAHL M
BOUMOAS D
SCOTT D
KLIPPEL J
BALOW J
STEINBERG A
Citation: M. Gourley et al., RANDOMIZED TRIAL OF MULTIPLE BOLUSES OF METHYLPREDNISOLONE (MP) OR CYCLOPHOSPHAMIDE (CY) OR THE COMBINATION (CY MP) IN PATIENTS WITH LUPUS NEPHRITIS/, Arthritis and rheumatism, 38(9), 1995, pp. 1434-1434
Citation: Gm. Wood et al., CHARACTERISTICS OF HPRT-MUTANT T-CELL LINES IN A LUPUS PATIENT TREATED WITH CYCLOPHOSPHAMIDE, Arthritis and rheumatism, 37(10), 1994, pp. 1548-1552
Citation: F. Martin et al., THE EFFECT OF ATTENTION ON MISMATCH NEGATIVITY TO AN OMITTED STIMULUS, Australian journal of psychology, 45(2), 1993, pp. 118-118